James Pehoushek, MD
Dermatology · Glendale, AZNPI 1104810720
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,274 of the $22,851 with a category attached, or 80.0%. It is spread thinly across 38 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Among dermatology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 952 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Johnson & Johnson$3K
- UCB, Inc.$2K
- Lilly USA, LLC$2K
- Novartis$1K
- Sun Pharmaceutical Industries Inc.$1K
- plus $8K from 32 others
Across 389 payments — averaging $12,292 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$4.2M
- UCB SA$344K
- Aclaris Therapeutics, Inc.$138K
- UCB Biosciences Inc.$35K
- Endo Pharmaceuticals Inc.$33K
- Pfizer$7K
- plus $4K from 1 others
What the payments were for
- Consulting fees$4,05018%
- Food & beverage$18,27480%
- Education$5272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 216 | $4,623 |
| Johnson & Johnson | 111 | $3,454 |
| UCB, Inc. | 64 | $2,358 |
| Lilly USA, LLC | 75 | $1,599 |
| Novartis | 76 | $1,367 |
| Sun Pharmaceutical Industries Inc. | 54 | $1,062 |
| Pfizer | 56 | $1,058 |
| Regeneron Healthcare Solutions, Inc. | 31 | $999 |
| Almirall LLC | 4 | $860 |
| Sanofi | 30 | $761 |
| Dermavant Sciences, Inc. | 35 | $733 |
| Amgen | 27 | $508 |
| Galderma Laboratories, L.p. | 33 | $483 |
| Incyte Corporation | 18 | $475 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 23 | $425 |
| LEO Pharma Inc. | 20 | $406 |
| E.r. Squibb & Sons, L.L.C. | 15 | $356 |
| Mayne Pharma Commercial LLC | 16 | $193 |
| Eli Lilly | 1 | $175 |
| Organon | 14 | $156 |
| Argenx US, Inc. | 1 | $108 |
| Stemline Therapeutics Inc. | 2 | $107 |
| GSK | 6 | $86 |
| Arcutis Biotherapeutics, Inc. | 3 | $65 |
| Revance Therapeutics, Inc. | 3 | $65 |
| Boehringer Ingelheim | 2 | $63 |
| Kyowa Kirin, Inc. | 3 | $59 |
| Botanix SB Inc | 2 | $42 |
| Journey Medical Corporation | 2 | $32 |
| Biofrontera Inc. | 1 | $31 |
| Sensus Healthcare, Inc. | 1 | $24 |
| Bristol Myers Squibb | 1 | $23 |
| EPI Health, LLC | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Biocon Biologics Inc | 1 | $15 |
| Merck | 1 | $14 |
| Phadia US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,851 in reported general payments places this provider in the 90th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 41 | $167,860 |
| Clobetasol Propionate | 129 | $8,133 |
| ValacyclovirValacyclovir Hcl | 83 | $2,493 |
| Fluocinonide | 59 | $2,376 |
| Ketoconazole | 117 | $1,716 |
| Triamcinolone Acetonide | 102 | $1,069 |
| Minoxidil | 55 | $826 |
| MethotrexateMethotrexate Sodium | 15 | $744 |
| Doxepin Hcl | 26 | $709 |
| Doxycycline Hyclate | 32 | $698 |
| Ammonium Lactate | 21 | $594 |
| Nystatin | 47 | $578 |
| Terbinafine Hcl | 27 | $563 |
| Spironolactone | 18 | $490 |
| Clindamycin Phosphate | 19 | $435 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Glendale
- Ryan StevensGlendale$14K
- Lindsay AckermanPhoenix$1.6M
- Kathleen ObrienTucson$742K
- Nathalie ZeitouniPhoenix$584K
- John KastelerGilbert$456K
- Anthony NuaraScottsdale$432K
- Carsten HamannPhoenix$364K
- James SlighTucson$238K
- Aaron MangoldScottsdale$171K
- Susan van DykeParadise Valley$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.